natgillin/translations-raw huggingface dataset:
Insulin administration into a vein for example to treat severe hyperglycaemia and ketoacidosis, requires experience and special safety precautions.
Dajanje insulina v veno, na primer. za zdravljenje hude hiperglikemije in ketoacidoze, zahteva izkušnje in posebne varnostne ukrepe.
Insulin administration into a vein for example to treat severe hyperglycaemia and ketoacidosis, requires experience and special safety precautions.
Dajanje insulina v veno, npr. za zdravljenje hude hiperglikemije in ketoacidoze, zahteva izkušnje in posebne varnostne ukrepe.
Insulin administration should be temporarily stopped and the next dose of insulin adjusted appropriately.
Uporabo insulina morate začasno prekiniti in naslednji odmerek insulina ustrezno prilagoditi.
Insulin administration via the pump can cause a fat infiltration of the liver at single, well-defined locations (called focal hepatic steatosis).
Dajanje insulina s črpalko lahko povzroči maščobno infiltracijo jeter na posameznih, dobro omejenih mestih (to imenujemo žariščna steatoza jeter).
Insulin and insulin secretagogues
Insulin in zdravila, ki spodbujajo izločanje insulina
Insulin and insulin secretagogues
Insulini in insulinski sekretagogi
Insulin and insulin secretagogues, such as sulphonylureas, cause hypoglycaemia.
Insulin in zdravila, ki spodbujajo izločanje insulina, kot so sulfonilsečnine, povzročajo hipoglikemijo.
insulin and oral antidiabetic products, certain long acting sulphonamides,
insulin in peroralni antidiabetiki, nekateri dolgodelujoči sulfonamidi,
Insulin and sulphonylureas are known to cause hypoglycaemia.
Znano je, da insulin in sulfonilsečnine povzročajo hipoglikemijo.
Insulin aspart is very slightly different from human insulin.
Insulin aspart se zelo malo razlikuje od humanega insulina.
Insulin Blister
insulinski pretisni omot
Insulin cartridge
insulinski vložek
Insulin cartridge
preostanka vložek
Insulin degludec and insulin aspart binds specifically to the human insulin receptor and results in the same pharmacological effects as human insulin.
Insulin degludek in insulin aspart se specifično vežeta na človeški receptor za insulin in imata enake farmakološke učinke kot humani insulin.
Insulin degludec and liraglutide are extensively bound to plasma proteins (> 99% and > 98%, respectively).
Insulin degludek in liraglutid se obsežno vežeta na beljakovine v plazmi (insulin degludek > 99 %, liraglutid pa > 98 %).
insulin degludec – a long-acting basal insulin which lowers your blood sugar levels. liraglutide – a ‘GLP-1 analogue’ that helps your body make more insulin during meals and lowers the amount of sugar made by your body.
insulin degludek - dolgodelujoči bazalni insulin, ki znižuje količino krvnega sladkorja in liraglutid - analog glukagonu podobnega peptida-1 (GLP-1), ki telesu pomaga proizvesti več insulina med obroki in znižuje količino v telesu nastalega sladkorja.
Insulin degludec, maximum 50 units allowed
insulin degludek, največji dovoljeni odmerek je 50 enot
Insulin delivery device
Injekcijski peresnik za insulin
insulin dependant diabetes diabetic ketoacidosis or diabetic coma.
diabetesom, odvisnim od insulina, diabetično ketoacidozo ali diabetično komo.
Insulin detemir is produced in Saccharomyces cerevisiae by recombinant DNA technology.
Insulin detemir je pridobljen iz Saccharomyces cerevisiae s tehnologijo rekombinantne DNA.
Insulin does cross the placental barrier, although not in clinically significant amount.
Insulin prestopa placentno pregrado, vendar ne v klinično pomembni količini.
Insulin does not cross the placental barrier.
Insulin ne prehaja skozi placentno pregrado.
Insulin dose (IU/day) at week 522
Odmerek insulina (i.e./dan) v 52. tednu2
Insulin dose (IU/day) at week 52b, 3
Odmerek insulina (i.e./dan) v 52. tednub, 3
insulin dose reduction of at
odmerka insulina za vsaj
Insulin glargine (N27) (CV%)
Insulin glargin (N27) (CV %)
Insulin glargine ( 20 units per day)
Insulin glargin ( 20 enot na dan)
Insulin glargine 100 units/ml was effective in managing diabetes in adults and children aged two years and above.
Insulin glargin 100 enot/ml je bilo učinkovito pri uravnavanju sladkorne bolezni pri odraslih in otrocih, starih dve leti in več.
Insulin glargine 100 units/ml was originally studied in 10 studies, in both type 1 diabetes (when the pancreas cannot produce insulin) and type 2 diabetes (when the body is unable to use insulin effectively).
Insulin glargin 100 enot/ml so najprej proučili v desetih študijah, v katere so bili vključeni bolniki s sladkorno boleznijo tipa 1 (pri kateri trebušna slinavka ne more tvoriti insulina) in bolniki s sladkorno boleznijo tipa 2 (pri kateri telo ne more učinkovito izrabiti insulina).
Insulin glargine and the metabolite M2 were not detectable in the vast majority of subjects and, when they were detectable their concentration was independent of the administered dose and formulation of insulin glargine.
Insulin glargin in presnovek M2 pri veliki večini preiskovancev nista bila zaznavna; če sta bila zaznavna, pa njuna koncentracija ni bila odvisna od uporabljenega odmerka in oblike insulina glargina.
Insulin glargine and the metabolite M2 were not detectable in the vast majority of subjects and, when they were detectable their concentration was independent of the administered dose of insulin glargine.
Insulin glargin in presnovek M2 pri veliki večini preiskovancev nista bila zaznavna; če sta bila zaznavna, pa njuna koncentracija ni bila odvisna od uporabljenega odmerka insulina glargin.
Insulin glargine and the metabolite M2 were not detectable in the vast majority of subjects and, when they were detectable their concentration was independent of the administered dose of Lantus.
Insulin glargin in presnovek M2 pri veliki večini preiskovancev nista bila zaznavna; če sta bila zaznavna, pa njuna koncentracija ni bila odvisna od uporabljenega odmerka zdravila Lantus.
Insulin glargine and the metabolite M2 were not detectable in the vast majority of subjects and, when they were detectable their concentration was independent of the administered dose of Toujeo.
Insulin glargin in presnovek M2 pri veliki večini preiskovancev nista bila zaznavna; če sta bila zaznavna, pa njuna koncentracija ni bila odvisna od uporabljenega odmerka zdravila Toujeo.
Insulin glargine did not alter the relative risk for CV disease and CV mortality when compared to standard of care.
Insulin glargin v primerjavi s standardnim zdravljenjem ni spremenil relativnega tveganja za srčno- žilno bolezen in srčno-žilno smrtnost.
Insulin glargine is a modified insulin, very similar to human insulin.
Insulin glargin je spremenjen insulin, zelo podoben humanemu insulinu.
Insulin glargine+ once daily (n=262)
10 mcg dvakrat na dan (n=276)
Insulin glargine, no limitation to dose
insulin glargin, največji odmerek ni določen
Insulin glargine1
Insulin glargin1
Insulin glargine3
insulin glargin3
Insulin glulisine administered 15 minutes after starting the meal gives similar glycemic control as regular human insulin given 2 minutes before the meal (see figure 1).
Insulin glulisin, uporabljen 15 minut po začetku obroka, doseže podobno urejenost glikemije kot navadni humani insulin, uporabljen 2 minuti pred obrokom (slika 1).
Insulin glulisine given 15 minutes (GLULISINE post) after start of a meal compared to regular human insulin given 2 minutes (REGULAR pre) before start of the meal (figure 1C).
Insulin glulisin, uporabljen 15 minut (GLULISIN - po) po začetku obroka, v primerjavi z navadnim humanim insulinom, uporabljenim 2 minuti (NAVADNI pred) pred začetkom obroka (slika 1C).
Insulin glulisine given 2 minutes (GLULISINE pre) before the start of a meal compared to regular human insulin given 30 minutes (REGULAR 30 min) before the start of the meal (figure 1A) and compared to regular human insulin given 2 minutes (REGULAR pre) before a meal (figure 1B).
Insulin glulisin, uporabljen 2 minuti (GLULISIN - pred) pred začetkom obroka, v primerjavi z navadnim humanim insulinom, uporabljenim 30 minut (NAVADNI - 30 min) pred začetkom obroka (slika 1A), in primerjava z navadnim humanim insulinom, uporabljenim 2 minuti (NAVADNI - pred) pred obrokom (slika 1B).
Insulin glulisine given 2 minutes (GLULISINE pre) before the start of a meal compared to regular human insulin given 30 minutes (REGULAR 30 min) before the start of the meal (figure 1A) and compared to regular human insulin given 2 minutes (REGULAR pre) before a meal (figure 1B).
Insulin glulisin, uporabljen 2 minuti (GLULISIN - pred) pred začetkom obroka, v primerjavi z navadnim humanim insulinom, uporabljenim 30 minut (NAVADNI -30 min) pred začetkom obroka (slika 1A), in primerjava z navadnim humanim insulinom, uporabljenim 2 minuti (NAVADNI -pred) pred obrokom (slika 1B).
Insulin glulisine QD
Insulin glulizin enkrat na dan
Insulin glulisine TID
Insulin glulizin trikrat na dan
Insulin glulisine was rapidly absorbed in both age groups, with similar Tmax and Cmax as in adults (see section 4.2).
V obeh starostnih skupinah se je insulin glulisin hitro absorbiral, tmax in Cmax sta bila podobna kot pri odraslih (glejte poglavje 4.2).
Insulin glulisine was rapidly absorbed in both age groups, with similar Tmax and Cmax as in adults (see section 4.2).
V obeh starostnih skupinah se je insulin glulisin hitro absorbiral. tmax in Cmax sta bila podobna kot pri odraslih (glejte poglavje 4.2).
Insulin glulisine.
. insulin glulisin
Insulin glulisine.
Insulin glulisin.
Insulin human
humani insulin
Insulin human SC, IV use
humani insulin za s.c. ali i.v. uporabo
Insulin Human Winthrop Basal
Insulin Human Winthrop Comb 15
Insulin Human Winthrop Basal
Insulin Human Winthrop Rapid
Insulin Human Winthrop Basal 100 IU/ml suspension for injection in a cartridge
Insulin Human Winthrop Basal 100 i.e./ml suspenzija za injiciranje v vložku
Insulin Human Winthrop Basal 100 IU/ml suspension for injection in a cartridge Insulin human
Insulin Human Winthrop Basal 100 i.e./ml suspenzija za injiciranje v vložku humani insulin
Insulin Human Winthrop Basal 100 IU/ml suspension for injection in a vial
Insulin Human Winthrop Basal 100 i.e./ml suspenzija za injiciranje v viali
Insulin Human Winthrop Basal 100 IU/ml suspension for injection in a vial Insulin human
Insulin Human Winthrop Basal 100 i.e./ml suspenzija za injiciranje v viali humani insulin
Insulin Human Winthrop Basal 100 IU/ml suspension for injection Insulin human
Insulin Human Winthrop Basal 100 i.e./ml suspenzija za injiciranje humani insulin
Insulin Human Winthrop Basal 40 IU/ml suspension for injection in a vial
Insulin Human Winthrop Basal 40 i.e./ml suspenzija za injiciranje v viali
Insulin Human Winthrop Basal 40 IU/ml suspension for injection in a vial Insulin human
Insulin Human Winthrop Basal 40 i.e./ml suspenzija za injiciranje v viali humani insulin
Insulin Human Winthrop Basal 40 IU/ml suspension for injection Insulin human
Insulin Human Winthrop Basal 40 i.e./ml suspenzija za injiciranje humani insulin
Insulin Human Winthrop Basal is injected under the skin 45 to 60 minutes before a meal.
Insulin Human Winthrop Basal injicirajte subkutano od 45 do 60 minut pred obrokom.
Insulin Human Winthrop Basal is supplied in pre-filled pens, SoloStar, containing 3 ml suspension (300 IU).
Insulin Human Winthrop Basal je na voljo v napolnjenih injekcijskih peresnikih SoloStar. ki vsebujejo 3 ml raztopine (300 i.e.).
Insulin Human Winthrop Basal may be mixed with all insulin human formulation, but not with those designed specifically for use in insulin pumps.
Insulin Human Winthrop Basal se sme mešati z vsemi humanimi insulini, razen s tistimi, ki so posebej pripravljeni za uporabo v insulinskih črpalkah.
Insulin Human Winthrop Basal may be mixed with all insulin human preparations, EXCEPT those specially designed for use in insulin pumps.
Insulin Human Winthrop Basal lahko mešate z vsemi pripravki s humanimim insulinom, RAZEN s tistimi, ki so posebej pripravljeni za uporabo v insulinskih črpalkah.
Insulin Human Winthrop Basal must never be injected intravenously.
Nikoli ga ne smemo injicirati intravensko.
Insulin Human Winthrop Basal must not be administered intravenously and must not be used in infusion pumps or external or implanted insulin pumps.
Zdravila Insulin Human Winthrop Basal se ne sme dajati intravensko in se ne sme uporabljati v infuzijskih črpalkah ali zunanjih ali vsajenih insulinskih črpalkah.
Insulin Human Winthrop Basal must not be mixed with any other insulin or with insulin analogues.
Zdravila Insulin Human Winthrop Basal se ne sme mešati z nobenim drugim insulinom ali insulinskimi analogi.
Insulin Human Winthrop Basal must not be used if this cannot be achieved, i.e. if the suspension remains clear, for example, or if clumps, particles or flocculation appear in the insulin or stick to the wall or bottom of the cartridge.
Insulina Insulin Human Winthrop Basal se ne sme uporabiti, če tega ni mogoče doseči – če suspenzija npr. ostane bistra, se v insulinu pojavijo grude, delci ali kosmi ali se lepijo na steno ali dno vložka.
Insulin Human Winthrop Basal must not be used if this cannot be achieved, i.e. if the suspension remains clear, for example, or if clumps, particles or flocculation appear in the insulin or stick to the wall or bottom of the cartridge.
Insulina Insulin Human Winthrop Basal se ne sme uporabiti, če tega ni mogoče doseči, tj. suspenzija npr. ostane bistra, se v insulinu pojavijo grude, delci ali kosmi ali se lepijo na steno ali dno vložka.
Insulin Human Winthrop Basal must not be used if this cannot be achieved, i.e. if the suspension remains clear, for example, or if clumps, particles or flocculation appear in the insulin or stick to the wall or bottom of the vial.
Insulina Insulin Human Winthrop Basal se ne sme uporabiti, če tega ni mogoče doseči – če suspenzija npr. ostane bistra, se v insulinu pojavijo grude, delci ali kosmi ali se lepijo na steno ali dno viale.
Insulin Human Winthrop Basal SoloStar 100 IU/ml suspension for injection in a pre-filled pen.
Insulin Human Winthrop Basal SoloStar 100 i.e./ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku
Insulin Human Winthrop Basal SoloStar 100 IU/ml suspension for injection Insulin human
Insulin Human Winthrop Basal SoloStar 100 i.e./ml suspenzija za injiciranje humani insulin
Insulin Human Winthrop Basal with alcohol
Zdravilo Insulin Human Winthrop Basal skupaj z alkoholom
Insulin Human Winthrop Basal with alcohol.
Zdravilo Insulin Human Winthrop Basal skupaj z alkoholom
Insulin Human Winthrop Comb 15
Insulin Human Winthrop Rapid
Insulin Human Winthrop Comb 15 100 IU/ml suspension for injection in a cartridge
Insulin Human Winthrop Comb 15 100 i.e./ml suspenzija za injiciranje v vložku
Insulin Human Winthrop Comb 15 100 IU/ml suspension for injection in a cartridge Insulin human
Insulin Human Winthrop Comb 15 100 i.e./ml suspenzija za injiciranje v vložku humani insulin
Insulin Human Winthrop Comb 15 100 IU/ml suspension for injection in a vial
Insulin Human Winthrop Comb 15 100 i.e./ml suspenzija za injiciranje v viali
Insulin Human Winthrop Comb 15 100 IU/ml suspension for injection in a vial Insulin human
Insulin Human Winthrop Comb 15 100 i.e./ml suspenzija za injiciranje v viali humani insulin
Insulin Human Winthrop Comb 15 100 IU/ml suspension for injection Insulin human
Insulin Human Winthrop Comb 15 100 i.e./ml suspenzija za injiciranje humani insulin
Insulin Human Winthrop Comb 15 40 IU/ml suspension for injection in a vial
Insulin Human Winthrop Comb 15 40 i.e./ml suspenzija za injiciranje v viali
Insulin Human Winthrop Comb 15 40 IU/ml suspension for injection in a vial Insulin human
Insulin Human Winthrop Comb 15 40 i.e./ml suspenzija za injiciranje v viali humani insulin
Insulin Human Winthrop Comb 15 40 IU/ml suspension for injection Insulin human
Insulin Human Winthrop Comb 15 40 i.e./ml suspenzija za injiciranje humani insulin
Insulin Human Winthrop Comb 15 can be used during breast-feeding.
Zdravilo Insulin Human Winthrop Comb 15 je med dojenjem dovočljeno uporabljati.
Insulin Human Winthrop Comb 15 contains the active substance insulin human which is made by a biotechnology process and is identical with the body's own insulin.
Zdravilo Insulin Human Winthrop Comb 15 vsebuje zdravilno učinkovino humani insulin, ki je pridobljen biotehnološko in je popolnoma enak lastnemu telesnemu insulinu .
Insulin Human Winthrop Comb 15 is a biphasic isophane insulin suspension consisting of 15% dissolved insulin and 85% crystalline protamine insulin.
Insulin Human Winthrop Comb 15 je dvofazna suspenzija insulina izofana, sestavljena iz 15 % raztopljenega insulina in 85 % kristalnega protamin-insulina.
Insulin Human Winthrop Comb 15 is injected under the skin 30 to 45 minutes before a meal.
Zdravilo Insulin Human Winthrop Comb 15 injicirajte subkutano od 30 do 45 minut pred obrokom.
Insulin Human Winthrop Comb 15 is supplied in pre-filled pens, SoloStar, containing 3 ml suspension, (300 IU).
Insulin Human Winthrop Comb 15 je na voljo v napolnjenih injekcijskih peresnikih SoloStar. ki vsebujejo 3 ml raztopine (300 i.e.).
Insulin Human Winthrop Comb 15 may be mixed with all insulin human fomulations, but not with those designed specifically for use in insulin pumps.
Insulin Human Winthrop Comb 15 se sme mešati z vsemi humanimi insulini, razen s tistimi, ki so posebej pripravljeni za uporabo v insulinskih črpalkah.
Insulin Human Winthrop Comb 15 may be mixed with all insulin human formulations, but not with those designed specifically for use in insulin pumps.
Insulin Human Winthrop Comb 15 se sme mešati z vsemi humanimi insulini, razen s tistimi, ki so posebej pripravljeni za uporabo v insulinskih črpalkah.
Insulin Human Winthrop Comb 15 must also not be mixed with insulins of animal origin or with insulin analogues.
Zdravila Insulin Human Winthrop Comb15 prav tako ne smemo mešati z insulini živalskega izvora ali z insulinskimi analogi.
Insulin Human Winthrop Comb 15 must never be injected intravenously.
Nikoli ga ne smemo injicirati intravensko.
Insulin Human Winthrop Comb 15 must not be administered intravenously and must not be used in infusion pumps or external or implanted insulin pumps.
Insulina Insulin Human Winthrop Comb 15 se ne sme dajati intravensko in se ga ne sme uporabljati v infuzijskih črpalkah ali v zunanjih ali vsajenih insulinskih črpalkah.
Insulin Human Winthrop Comb 15 must not be used if this cannot be achieved, i.e. if the suspension remains clear, for example, or if clumps, particles or flocculation appear in the insulin or stick to the wall or bottom of the cartridge.
Insulina Insulin Human Winthrop Comb 15 se ne sme uporabiti, če tega ni mogoče doseči – če suspenzija npr. ostane bistra, se v insulinu pojavijo grude, delci ali kosmi ali se lepijo na steno ali dno vložka.
Insulin Human Winthrop Comb 15 must not be used if this cannot be achieved, i.e. if the suspension remains clear, for example, or if clumps, particles or flocculation appear in the insulin or stick to the wall or bottom of the cartridge.
Insulina Insulin Human Winthrop Comb 15 se ne sme uporabiti, če tega ni mogoče doseči, tj. suspenzija npr. ostane bistra, se v insulinu pojavijo grude, delci ali kosmi ali se lepijo na steno ali dno vložka.
Insulin Human Winthrop Comb 15 must not be used if this cannot be achieved, i.e. if the suspension remains clear, for example, or if clumps, particles or flocculation appear in the insulin or stick to the wall or bottom of the vial.
Insulina Insulin Human Winthrop Comb 15 se ne sme uporabiti, če tega ni mogoče doseči – če suspenzija npr. ostane bistra, se v insulinu pojavijo grude, delci ali kosmi ali se lepijo na steno ali dno viale.
Insulin Human Winthrop Comb 15 SoloStar 100 IU/ml suspension for injection in a pre-filled pen.
Insulin Human Winthrop Comb 15 SoloStar 100 i.e./ml suspenzija za injiciranje v napolnjenem injekcijskem peresniku
Insulin Human Winthrop Comb 15 SoloStar 100 IU/ml suspension for injection Insulin human
Insulin Human Winthrop Comb 15 SoloStar 100 i.e./ml suspenzija za injiciranje humani insulin
Insulin Human Winthrop Comb 15: 15% soluble insulin and 85% crystalline protamine insulin;
Insulin Human Winthrop Comb 15: 15 % topnega insulina in 85 % kristalnega protamin-insulina,
Insulin Human Winthrop Comb 25
Insulin Human Winthrop Rapid
Insulin Human Winthrop Comb 25 100 IU/ml suspension for injection in a cartridge
Insulin Human Winthrop Comb 25 100 i.e./ml suspenzija za injiciranje v vložku
Insulin Human Winthrop Comb 25 100 IU/ml suspension for injection in a cartridge Insulin human
Insulin Human Winthrop Comb 25 100 i.e./ml suspenzija za injiciranje v vložku humani insulin
Insulin Human Winthrop Comb 25 100 IU/ml suspension for injection in a vial
Insulin Human Winthrop Comb 25 100 i.e./ml suspenzija za injiciranje v viali
Insulin Human Winthrop Comb 25 100 IU/ml suspension for injection in a vial Insulin human
Insulin Human Winthrop Comb 25 100 i.e./ml suspenzija za injiciranje v viali humani insulin
Insulin Human Winthrop Comb 25 100 IU/ml suspension for injection Insulin human
Insulin Human Winthrop Comb 25 100 i.e./ml suspenzija za injiciranje v viali humani insulin
Insulin Human Winthrop Comb 25 100 IU/ml suspension for injection Insulin human
Insulin Human Winthrop Comb 25 100 i.e./ml suspenzija za injiciranje v vložku humani insulin
Insulin Human Winthrop Comb 25 40 IU/ml suspension for injection in a vial
Insulin Human Winthrop Comb 25 40 i.e./ml suspenzija za injiciranje v viali
Insulin Human Winthrop Comb 25 40 IU/ml suspension for injection in a vial Insulin human
Insulin Human Winthrop Comb 25 40 i.e./ml suspenzija za injiciranje v viali humani insulin
Insulin Human Winthrop Comb 25 40 IU/ml suspension for injection Insulin human
Insulin Human Winthrop Comb 25 40 i.e./ml suspenzija za injiciranje humani insulin
Insulin Human Winthrop Comb 25 alcohol
Zdravilo Insulin Human Winthrop Comb 25 skupaj z alkoholom
Insulin Human Winthrop Comb 25 is injected under the skin 30 to 45 minutes before a meal.
Zdravilo Insulin Human Winthrop Comb 25 injicirajte subkutano od 30 do 45 minut pred obrokom.
Insulin Human Winthrop Comb 25 is supplied in pre-filled pens, SoloStar, containing 3 ml suspension, (300 IU).
Insulin Human Winthrop Comb 25 je na voljo v napolnjenih injekcijskih peresnikih SoloStar. ki vsebujejo 3 ml raztopine (300 i.e.).
Insulin Human Winthrop Comb 25 may be mixed with all insulin human formulations, but not with those designed specifically for use in insulin pumps.
Insulin Human Winthrop Comb 25 se sme mešati z vsemi humanimi insulini, razen s tistimi, ki so posebej pripravljeni za uporabo v insulinskih črpalkah.
Insulin Human Winthrop Comb 25 must never be injected intravenously.
Nikoli ga ne smemo injicirati intravensko.
Insulin Human Winthrop Comb 25 must not be administered intravenously and must not be used in infusion pumps or external or implanted insulin pumps.
Insulina Insulin Human Winthrop Comb 25 se ne sme dajati intravensko in se ga ne sme uporabljati v infuzijskih črpalkah ali v zunanjih ali vsajenih insulinskih črpalkah.
Insulin Human Winthrop Comb 25 must not be mixed with any other insulin or with insulin analogues.
Zdravila Insulin Human Winthrop Comb25 prav tako ne smemo mešati z insulini živalskega izvora ali z insulinskimi analogi.
Insulin Human Winthrop Comb 25 must not be used if this cannot be achieved, i.e. if the suspension remains clear, for example, or if clumps, particles or flocculation appear in the insulin or stick to the wall or bottom of the cartridge.
Insulina Insulin Human Winthrop Comb 25 se ne sme uporabiti, če tega ni mogoče doseči – če suspenzija npr. ostane bistra, se v insulinu pojavijo grude, delci ali kosmi ali se lepijo na steno ali dno vložka.
Insulin Human Winthrop Comb 25 must not be used if this cannot be achieved, i.e. if the suspension remains clear, for example, or if clumps, particles or flocculation appear in the insulin or stick to the wall or bottom of the cartridge.
Insulina Insulin Human Winthrop Comb 25 se ne sme uporabiti, če tega ni mogoče doseči, tj. suspenzija npr. ostane bistra, se v insulinu pojavijo grude, delci ali kosmi ali se lepijo na steno ali dno vložka.